Ryan Dustin Moll

Ryan Moll practices at Canonsburg Hospital in Canonsburg, Pennsylvania, part of Highmark Health.

Ryan Moll's NPI, 1598262362, was assigned on April 9, 2018. Ryan Moll graduated from Lake Erie College of Osteopathic Medicine, Erie in 2018. Ryan Moll holds Pennsylvania license OS021401.

Ryan Moll's primary practice is Canonsburg Hospital, at 100 Medical Boulevard, Canonsburg, PA 15317 in Washington County. The practice phone is (724) 745-6100.

Ryan Moll's primary practice is Canonsburg Hospital in Canonsburg, Pennsylvania, part of Highmark Health. Ryan Moll is also affiliated with Allegheny General Hospital. The medical group on file is AHN Primary Care - Family Med Associates at H+W Pavilion Bethel Park. Dmand AI also links Ryan Moll to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ryan Moll practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Ryan Moll's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Ryan Moll is licensed in Pennsylvania.

CMS data shows 215 Medicare services from Ryan Moll across 3 procedure codes in 2024, for 56 Medicare patients. Medicare paid $12,514 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 56 Medicare patients who saw Ryan Moll in 2024. The largest group is 65 to 74, with 26 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 20% are also on Medicaid. Their average risk score is 3.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ryan Moll's median patient age at 72, with 47% women.

In 2024, Ryan Moll wrote 237 Medicare Part D claims for 82 patients. 94% of them were for generic drugs. CMS names the drug for 64 of them, across 4 drugs with 11 or more claims each, at $426 in total drug cost. In 2023, CMS named 111 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Ryan Moll for performance year 2024, reported through an alternative payment model (APM). Ryan Moll accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Ryan Moll in 2025. The most frequent topics are Molecular Targeted Therapy. Ryan Moll's most frequent co-authors are Veli Bakalov, MD, Larisa Greenberg, MD and Gurveen Kaur.

CMS Open Payments shows 1 general payment to Ryan Moll from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $83.

Ryan Moll graduated from Lake Erie College of Osteopathic Medicine, Erie in 2018.